Invention Grant
- Patent Title: Inhibitors of protein kinases
- Patent Title (中): 蛋白激酶抑制剂
-
Application No.: US12451042Application Date: 2008-04-24
-
Publication No.: US08436007B2Publication Date: 2013-05-07
- Inventor: Philipp Wabnitz , Heike Schauerte , Hans Allgeier , Martin Augustin , Lutz Zeitlmann , Michael A. Pleiss , Gabriele Stumm , Anke Mueller
- Applicant: Philipp Wabnitz , Heike Schauerte , Hans Allgeier , Martin Augustin , Lutz Zeitlmann , Michael A. Pleiss , Gabriele Stumm , Anke Mueller
- Applicant Address: DE Martinsried
- Assignee: Ingenium Pharmaceuticals GmbH
- Current Assignee: Ingenium Pharmaceuticals GmbH
- Current Assignee Address: DE Martinsried
- Agency: Olson & Cepuritis, Ltd.
- Priority: WOPCT/EP2007/003602 20070424
- International Application: PCT/EP2008/054975 WO 20080424
- International Announcement: WO2008/129070 WO 20081030
- Main IPC: C07D239/42
- IPC: C07D239/42 ; A61K31/505
Abstract:
The present invention relates to inhibitors of cyclin-dependent kinases and therapeutic applications thereof. Furthermore, the invention relates to methods of preventing and/or treating any type of pain, inflammatory disorders, immunological diseases, proliferative diseases, infectious diseases, cardiovascular diseases and neurodegenerative diseases comprising the administration of an effective amount of at least one inhibitor of cyclin-dependent kinases.
Public/Granted literature
- US20100184789A1 INHIBITORS OF PROTEIN KINASES Public/Granted day:2010-07-22
Information query
